Yield10 Bioscience announced that it signed a non-binding Letter of Intent, LOI, with BioMar Group, a global aquafeed producer, to form a partnership to commercialize Camelina engineered to produce omega-3 oil for use as a high-quality supplement to the scarce supply of marine long-chain fatty acids used in aquafeed. Producing omega-3 oil in Camelina represents a land-based way to make this key aquafeed ingredient. These new Omega-3 Camelina products contain EPA and DHA at levels comparable to many of the marine oil sources utilized today. It is ideally designed for the needs of the aquaculture industry and is a complementary fit into the BioMar Omega Technology concept together with other sources of essential omega-3s. “A partnership with BioMar has the potential to combine the strengths of both companies for the accelerated development of Camelina produced omega-3 oils. We look forward to working closely with BioMar to develop a collaborative program to bring this new source of high-quality EPA and EPA+DHA omega-3 oils to the market to strive to meet the aquaculture industry’s growth demand and sustainability goals,” said Oliver Peoples, Ph.D. President and CEO, Yield10 Bioscience.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on YTEN:
- Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land
- Yield10 Bioscience finalize global license to advance Camelina technology
- Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
- Yield10 provides update on recent advancement in development of Camelina
- Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina